Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02303041
Title Erismodegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stanford University

basal cell carcinoma


Buparlisib + Sonidegib

Age Groups: adult
Covered Countries USA

No variant requirements are available.